FDA approves Lexapro

The U.S. Food and Drugs Administration has approved the anti-depressant Lexapro to treat depression in children between 12 and 17 and as a 'maintenance' therapy to maintain control of symptoms in this age group.

You can find out more about the background to the licensing of this drug at

http://uk.reuters.com/article/healthNews/idUKTRE52J5KZ20090320?feedType=RSS&feedName=healthNews&sp=true